A detailed history of Spirepoint Private Client, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 2,000 shares of NVO stock, worth $170,000. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,114 5.39%
Holding current value
$170,000
Previous $302 Million 21.08%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $13,573 - $16,577
-114 Reduced 5.39%
2,000 $238 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $215,860 - $287,334
2,114 New
2,114 $271 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.